The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial

INTRODUCTION: Cardiovascular disease is the leading cause of morbidity and mortality in patients with type 2 diabetes (T2D). Although glycaemic control reduces microvascular complications, the effect of intensive treatment strategies or individual drugs on macrovascular diseases is still debated. RN...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Emil List, Cejvanovic, Vanja, Kjær, Laura Kofoed, Vilsbøll, Tina, Knop, Filip Krag, Rungby, Jørgen, Poulsen, Henrik Enghusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Open 2017
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623443/
https://www.ncbi.nlm.nih.gov/pubmed/28490557
http://dx.doi.org/10.1136/bmjopen-2016-014728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623443/
https://www.ncbi.nlm.nih.gov/pubmed/28490557
http://dx.doi.org/10.1136/bmjopen-2016-014728

Ejemplares similares